Evidence map›Paper›PMID 42096309›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

A PKA-selective inhibitor captures an open but more ordered conformation of the PKA catalytic subunit.

Jessica G H Bruystens, Jian Wu, Gerald Tan, Daniela Bertinetti, Hans-Michael Zenn, Bastian Zimmermann, Lisa Chen, Johannes Köckenberger, Federica Massaro, Banumathi Sankaran and 5 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jessica G H BruystensDepartment of Pharmacology, University of California San Diego, La Jolla, CA 92093.
Jian WuDepartment of Pharmacology, University of California San Diego, La Jolla, CA 92093.
Gerald TanDepartment of Pharmacology, University of California San Diego, La Jolla, CA 92093.
Daniela BertinettiDepartment of Biochemistry, University of Kassel, Kassel 34109, Germany.ORCID 0000-0003-1150-3765
Hans-Michael ZennBiaffin GmBH & CoKG, Kassel 34132, Germany.
Bastian ZimmermannBiaffin GmBH & CoKG, Kassel 34132, Germany.
Lisa ChenDepartment of Pharmacology, University of California San Diego, La Jolla, CA 92093.
Johannes KöckenbergerDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093.
Federica MassaroDepartment of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota.
Banumathi SankaranMolecular Biophysics and Integrated Bioimaging, Berkeley Center for Structural Biology, Lawrence Berkeley National Lab, Berkeley, CA 94720.
Matthew S WaltersDepartment of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota.ORCID 0009-0006-2734-2467
Gianluigi VegliaDepartment of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota.ORCID 0000-0002-2795-6964
Fleur M FergusonDepartment of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093.
Friedrich W HerbergDepartment of Biochemistry, University of Kassel, Kassel 34109, Germany.ORCID 0000-0001-7117-7653
Susan S TaylorDepartment of Pharmacology, University of California San Diego, La Jolla, CA 92093.ORCID 0000-0002-7702-6108

Funding

Contemporary Approaches to Cancer Cell Signaling and CommunicationT32CA009523 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DONOGHUE, DANIEL J, YANG, JING · 1985 to 2025
$12.1M
HHS | NIH | NIH Office of the Director (OD) CA290129HHS | NIH | NIH Office of the Director (OD) GM124169HHS | NIH | NIH Office of the Director (OD) GM130389HHS | NIH | NIH Office of the Director (OD) T32CA009523
6 · The paper itself

Abstract

The structure of the catalytic subunit of cAMP-dependent protein kinase (PKA-C), a prototype for the protein kinase superfamily, laid the foundation for the development of targeted kinase inhibitors. Here we describe the structure and biophysical characterization of a PKA-C complex with BLU0588, a small PKA-selective inhibitor. The high-resolution crystal structure not only captures the inhibitor's unusual T-shaped geometry, but also shows how the four rings of BLU0588 serve as surrogates for ATP's adenosine and phosphate-organizing sites. Each site contains two subsites. BLU0588's planar azaindole and pyridine rings, which are buried beneath the glycine-rich loop in a hydrophobic shell at the base of the active site cleft, fill the adenine and ribose subsites. In contrast, BLU0588's indane and pyrrolidine rings fill the phosphate-organizing site. The indane ring occupies the α/β-phosphate organizing site while the pyrrolidine ring fills the Mg/γ-phosphate organizing site. The structure also shows how BLU0588 nucleates an open but stable conformation of the entire hydrophobic architecture of the N- and C-lobes. In addition to potently blocking phosphoryl transfer activity, BLU0588 also abolishes the synergistic high-affinity binding of the physiological pseudosubstrate inhibitor, protein kinase inhibitor. The residence time of BLU0588, measured by surface plasmon residence, contributes to its picomolar affinity and is distinct from H89, a commonly used but more promiscuous PKA inhibitor. These molecular insights provide a valuable framework for dissecting the organization of the active site cleft as well as different strategies for the rational design of more potent and selective kinase inhibitors in general.

Indexed as

Cyclic AMP-Dependent Protein Kinase Catalytic SubunitsCyclic AMP-Dependent Protein KinasesProtein Kinase InhibitorsCatalytic DomainCrystallography, X-RayModels, MolecularProtein ConformationCyclic AMP-Dependent Protein Kinase Catalytic SubunitsCyclic AMP-Dependent Protein KinasesProtein Kinase InhibitorscAMP-dependent protein kinasecatalytic subunitcrystal structurePKA-selective inhibitorSPR measurement

Identifiers

PMID42096309
PMCPMC13167742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.